EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

User Centered Rare Disease Clinical Trial Knowledge Graph (RCTKG)

Jeremy Parker Yang, Devon Leadman, Richard M Ballew, Eric Sid, Yanji Xu, Ewy A Mathé, Qian Zhu

Studies in Health Technology and Informatics · 2024

DOI: 10.3233/shti230934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, 2024. Verfasst von Jeremy Parker Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Wisconsin-Madison, Madison, WI, US. Hauptthemen laut MEDLINE: Rare Diseases, Pattern Recognition, Automated. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug development in rare diseases is challenging due to the limited availability of subjects with the diseases and recruiting from a small patient population. The high cost and low success rate of clinical trials motivate deliberate analysis of existing clinical trials to understand status of clinical development of orphan drugs and discover new insight for new trial. In this project, we aim to develop a user centered Rare disease based Clinical Trial Knowledge Graph (RCTKG) to integrate publicly available clinical trial data with rare diseases from the Genetic and Rare Disease (GARD) program in a semantic and standardized form for public use. To better serve and represent the interests of rare disease users, user stories were defined for three types of users, patients, healthcare providers and informaticians, to guide the RCTKG design in supporting the GARD program at NCATS/NIH and the broad clinical/research community in rare diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesPattern Recognition, AutomatedHumansHealth PersonnelKnowledge

Stichwörter der Autor:innen

Clinical trialdata modelknowledge graphrare diseaseuser story

Autor:innen und Institutionen

  • University of Wisconsin-Madison, Madison, WI, US.
  • Division of Rare Diseases Research Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, US.
  • ICF International Inc, Rockville, MD, US.
  • Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, US.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Yang, J. P., Leadman, D., Ballew, R. M., Sid, E., Xu, Y., Mathé, E. A., & Zhu, Q. (2024). User Centered Rare Disease Clinical Trial Knowledge Graph (RCTKG). Studies in Health Technology and Informatics. https://doi.org/10.3233/shti230934

Vancouver

Yang JP, Leadman D, Ballew RM, Sid E, Xu Y, Mathé EA, et al. User Centered Rare Disease Clinical Trial Knowledge Graph (RCTKG). Studies in Health Technology and Informatics. 2024. doi:10.3233/shti230934

BibTeX
@article{Yang2024,
  author = {Yang, Jeremy Parker and Leadman, Devon and Ballew, Richard M and Sid, Eric and Xu, Yanji and Mathé, Ewy A and Zhu, Qian},
  title = {User Centered Rare Disease Clinical Trial Knowledge Graph (RCTKG)},
  journal = {Studies in Health Technology and Informatics},
  year = {2024},
  doi = {10.3233/shti230934}
}
Kostenlos starten →